BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12670347)

  • 1. Induction of cyclooxygenase-1 and -2 modulates angiogenic responses to engagement of alphavbeta3.
    Murphy JF; Steele C; Belton O; Fitzgerald DJ
    Br J Haematol; 2003 Apr; 121(1):157-64. PubMed ID: 12670347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase-2: a therapeutic target in angiogenesis.
    Iñiguez MA; Rodríguez A; Volpert OV; Fresno M; Redondo JM
    Trends Mol Med; 2003 Feb; 9(2):73-8. PubMed ID: 12615041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engagement of CD44 modulates cyclooxygenase induction, VEGF generation, and proliferation in human vascular endothelial cells.
    Murphy JF; Lennon F; Steele C; Kelleher D; Fitzgerald D; Long AC
    FASEB J; 2005 Mar; 19(3):446-8. PubMed ID: 15640281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential involvement of the cyclooxygenase-2 pathway in the regulation of tumor-associated angiogenesis and growth in pancreatic cancer.
    Chu J; Lloyd FL; Trifan OC; Knapp B; Rizzo MT
    Mol Cancer Ther; 2003 Jan; 2(1):1-7. PubMed ID: 12533667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase-1 is overexpressed and promotes angiogenic growth factor production in ovarian cancer.
    Gupta RA; Tejada LV; Tong BJ; Das SK; Morrow JD; Dey SK; DuBois RN
    Cancer Res; 2003 Mar; 63(5):906-11. PubMed ID: 12615701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PGE(2) is generated by specific COX-2 activity and increases VEGF production in COX-2-expressing human pancreatic cancer cells.
    Eibl G; Bruemmer D; Okada Y; Duffy JP; Law RE; Reber HA; Hines OJ
    Biochem Biophys Res Commun; 2003 Jul; 306(4):887-97. PubMed ID: 12821125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase-2 promotes prostate cancer progression.
    Fujita H; Koshida K; Keller ET; Takahashi Y; Yoshimito T; Namiki M; Mizokami A
    Prostate; 2002 Nov; 53(3):232-40. PubMed ID: 12386924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase-2-dependent prostacyclin formation is regulated by low density lipoprotein cholesterol in vitro.
    Smith LH; Boutaud O; Breyer M; Morrow JD; Oates JA; Vaughan DE
    Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):983-8. PubMed ID: 12067908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human lymphocytes stimulate prostacyclin synthesis in human umbilical vein endothelial cells. Involvement of endothelial cPLA2.
    Merhi-Soussi F; Dominguez Z; Macovschi O; Dubois M; Savany A; Lagarde M; Prigent AF
    J Leukoc Biol; 2000 Dec; 68(6):881-9. PubMed ID: 11129656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2.
    Hernández GL; Volpert OV; Iñiguez MA; Lorenzo E; Martínez-Martínez S; Grau R; Fresno M; Redondo JM
    J Exp Med; 2001 Mar; 193(5):607-20. PubMed ID: 11238591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclooxygenase-2 in human and experimental ischemic proliferative retinopathy.
    Sennlaub F; Valamanesh F; Vazquez-Tello A; El-Asrar AM; Checchin D; Brault S; Gobeil F; Beauchamp MH; Mwaikambo B; Courtois Y; Geboes K; Varma DR; Lachapelle P; Ong H; Behar-Cohen F; Chemtob S
    Circulation; 2003 Jul; 108(2):198-204. PubMed ID: 12821538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2 overexpression correlates with vascular endothelial growth factor expression and tumor angiogenesis in gastric cancer.
    Joo YE; Rew JS; Seo YH; Choi SK; Kim YJ; Park CS; Kim SJ
    J Clin Gastroenterol; 2003 Jul; 37(1):28-33. PubMed ID: 12811205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of COX-2 in VEGF-treated endothelial cells is mediated through protein tyrosine kinase.
    Akarasereenont PC; Techatraisak K; Thaworn A; Chotewuttakorn S
    Mediators Inflamm; 2002 Feb; 11(1):17-22. PubMed ID: 11926591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of selective cyclooxygenase-2 inhibitors in the management of tumor angiogenesis.
    Gately S; Kerbel R
    Prog Exp Tumor Res; 2003; 37():179-92. PubMed ID: 12795055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation.
    Gryglewski RJ; Chłopicki S; Uracz W; Marcinkiewicz E
    Med Sci Monit; 2001; 7(1):1-16. PubMed ID: 11208485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial cell integrins and COX-2: mediators and therapeutic targets of tumor angiogenesis.
    Rüegg C; Dormond O; Mariotti A
    Biochim Biophys Acta; 2004 Mar; 1654(1):51-67. PubMed ID: 14984767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2.
    Soldi R; Mitola S; Strasly M; Defilippi P; Tarone G; Bussolino F
    EMBO J; 1999 Feb; 18(4):882-92. PubMed ID: 10022831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COX-2 and angiogenesis in gastric cancer.
    Walther Z
    J Clin Gastroenterol; 2003 Jul; 37(1):4-6. PubMed ID: 12811200
    [No Abstract]   [Full Text] [Related]  

  • 19. Vascular endothelial growth factor upregulates constitutive cyclooxygenase 1 in primary bovine and human endothelial cells.
    Bryant CE; Appleton I; Mitchell JA
    Life Sci; 1998; 62(24):2195-201. PubMed ID: 9627078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochrome P4502C9-derived epoxyeicosatrienoic acids induce the expression of cyclooxygenase-2 in endothelial cells.
    Michaelis UR; Falck JR; Schmidt R; Busse R; Fleming I
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):321-6. PubMed ID: 15569819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.